Startups
OPXBIO uses its proprietary, leading EDGE™ (Efficiency Directed Genome Engineering) technology to manufacture renewable bio-based chemicals and fuels that are lower cost, higher return and more sustainable than existing petroleum-based products. In addition to DBL Partners, investors include:X/Seed Capital, USRG, Mohr Davidow, Braemar Energy Ventures and Wolfensohn & Co.
Overview
Location
United States, Colorado, Boulder
Employees
11-50
Total raised
$36.5M
Founded date
2007
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| May 8, 2021 | DBL Partners | dblpartners.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 1
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
Reviews 0
FAQ about OPX Biotechnologies
When was OPX Biotechnologies founded?
OPX Biotechnologies was founded in 2007.
How much funding has OPX Biotechnologies raised?
OPX Biotechnologies has raised $36.5M in total across 1 funding round.
Who has invested in OPX Biotechnologies?
Parsers VC lists 2 investors of OPX Biotechnologies, among them DBL Partners.
Is OPX Biotechnologies still active?
Yes, OPX Biotechnologies is active; its latest activity on Parsers VC dates from May 8, 2021.